
| 20–27 November 20 November –1 December 2017 |
Welcome from the Chair of the 2nd International Electronic Conference of Metabolomics (IECM-2)
Building in the success of the 1st International Electronic Conference of Metabolomics (IECM-1) in 2016, Metabolites (ISSN 2218-1989), a peer-reviewed, scientific journal, edited by MDPI AG, is proud to be the organizer and sponsor of the second International Electronic Conference on Metabolomics. Contributions dealing with any discipline promoting metabolism and metabolomics will be welcomed.
The conference will be held online (https://sciforum.net/conference/iecm-2) from
,enabling you to present your latest research to the scientific community and to have the opportunity to participate in fruitful exchanges of information with academic and industrial groups from all over the world. It is absolutely free of charge to participate as an author or a visitor; all you need to do is create an account on the home page. Accepted full papers will be published in the Journal Proceedings. After the conference, the authors are also welcome to submit an extended version of the proceeding papers to the Special Issue of Journal Metabolites with 20% discount of the APC charges.
On behalf of our active scientific committee and dynamic editorial staff, we warmly invite you to join us at the second International Electronic Conference on Metabolomics and we look forward to posting your contribution.
Sincerely yours,
|
Chair of the 2nd International Electronic Conference on Metabolomics |
![]() |
A/Prof Peter Meikle is a NHMRC Senior Research Fellow, Obesity and Diabetes Program Leader and Head of the Metabolomics Laboratory at Baker Heart and Diabetes Institute. He is Editor-in-Chief of Metabolites and holds affiliate positions at the University of Melbourne, Monash University and the University of Sydney. The Metabolomics Laboratory has a focus on the dyslipidemia and altered lipid metabolism associated with obesity, diabetes and cardiovascular disease and its relationship to the pathogenesis of these disease states. This work is leading to new approaches to early diagnosis and risk assessment as well as the development of new lipid modulating therapies for chronic disease.



MDPI AG, the publisher of the Sciforum.net platform, is an open access publisher. We believe that authors should retain the copyright to their research works. Hence, by submitting a contribution to this conference, the authors retain the copyright of their contribution, but they grant MDPI AG the non-exclusive right to publish this contribution online on the Sciforum.net platform. This means the authors can easily submit their contribution to any scientific journal at a later stage and transfer the copyright to its publisher (if required by that publisher).
The conference will be held online (https://sciforum.net/conference/iecm-2) from 20–27 November 20 November –1 December 2017. Scientists have been accustomed to attend conferences, as they are an integral part of the scientific communication cycle. However, conferences require scientists for costly and time-consuming travels across the globe. E-Conferences are here to reduce the additional burden of attending physical conferences: one can attend an e-conference from any place with Internet access and presentations from e-conferences can be attended online at any time. All participants can share ideas online without time and space barriers.
The conference will cover a wide range of topics in metabolomics. A non exhaustive list of that will be considered comprises:
Section A: Neurological Metabolomics
Section B: Nutrimetabolomics and Pharmaceutical Research
Section C: Plant and Microbial Metabolomics
Section D: Clinical Applications of Metabolomics
Section E: Technological Advances in Metabolomics (including Bioinformatics)